Article

Structural basis for a new mechanism of inhibition of HIV-1 integrase identified by fragment screening and structure-based design.

Avexa Ltd, Richmond, Australia.
Antiviral chemistry & chemotherapy 01/2011; 21(4):155-68. DOI: 10.3851/IMP1716
Source: PubMed

ABSTRACT HIV-1 integrase is a clinically validated therapeutic target for the treatment of HIV-1 infection, with one approved therapeutic currently on the market. This enzyme represents an attractive target for the development of new inhibitors to HIV-1 that are effective against the current resistance mutations.
A fragment-based screening method employing surface plasmon resonance and NMR was initially used to detect interactions between integrase and fragments. The binding sites of the fragments were elucidated by crystallography and the structural information used to design and synthesize improved ligands.
The location of binding of fragments to the catalytic core of integrase was found to be in a previously undescribed binding site, adjacent to the mobile loop. Enzyme assays confirmed that formation of enzyme-fragment complexes inhibits the catalytic activity of integrase and the structural data was utilized to further develop these fragments into more potent novel enzyme inhibitors.
We have defined a new site in integrase as a valid region for the structure-based design of allosteric integrase inhibitors. Using a structure-based design process we have improved the activity of the initial fragments 45-fold.

1 Follower
 · 
142 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: In this study, four computational quantitative structure-activity relationship (QSAR) models were built to predict the bioactivity of 3' processing (3'P) inhibitors of HIV-1 integrase. Some 453 inhibitors whose bioactivity values were detected by the radiolabelling method were collected. The molecular structures were represented with MOE descriptors. In total, 21 descriptors were selected for modelling. All inhibitors were divided into a training set and a test set with two methods: (1) by a Kohonen's self-organizing map (SOM); (2) by a random selection. For every training set and test set, a multilinear regression (MLR) analysis and a support vector machine (SVM) were used to establish models, respectively. For the training/test set divided by SOM, the correlation coefficients (r) were over 0.84, and for the training/test set split randomly, the r values were over 0.86. Some molecular properties such as hydrogen bond donor capacity, atomic partial charge properties, molecular refractivity, the number of aromatic bonds and molecular surface area, volume and shape properties played important roles for inhibiting 3' processing step of HIV-1 integrase.
    SAR and QSAR in Environmental Research 08/2014; 25(9):1-18. DOI:10.1080/1062936X.2014.942695 · 1.92 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Inhibition of the 3′ processing step of HIV-1 integrase by small molecule inhibitors is one of the most promising strategies for the treatment of AIDS. Using a support vector machine (SVM) approach, we developed six classification models for predicting 3′P inhibitors. The models are based on up to 48 selected molecular descriptors and a comprehensive data set of 1253 molecules, with measured activities ranging from nanomolar to micromolar IC50 values. Model B2, the most robust SVM model, obtains a prediction accuracy, sensitivity, specificity and Matthews correlation coefficient (MCC) of 93 %, 81 %, 94 % and 0.67 on the test set, respectively. The presence of hydrogen bonding features and hydrophilicity in general were identified as key determinants of inhibitory activity. Further important properties include molecular refractivity, π atom charge, total charge, lone pair electronegativity, and effective atom polarizability. Comparative fragment-based analysis of the active and inactive molecules corroborated these observations and revealed several characteristic structural elements of 3′P inhibitors. The models built in this study can be obtained from the authors.
    10/2013; 32(9‐10). DOI:10.1002/minf.201300107
  • [Show abstract] [Hide abstract]
    ABSTRACT: Aryl- and N-substituted isatins were converted to isa-tin-3-hydrazones and subjected to a dichlorination re-action with PhICl2. Lewis base-catalysis was key to the reaction occurring rapidly and chemoselectively, providing 3,3-dichloroindolin-2-ones in 49-99% yield, and offering a new approach to the deoxygenative di-halogenation reaction.
    Organic & Biomolecular Chemistry 11/2014; 13(3). DOI:10.1039/C4OB02213K · 3.49 Impact Factor

Full-text

Download
72 Downloads
Available from
May 30, 2014